CVS Caremark to list Wegovy as preferred GLP-1 drug on top formularies starting July 1, 2025. Novo Nordisk plans continued collaboration with CVS to widen Wegovy access. 3 Summer "Power Patterns ...

CVS’ pharmacy benefit manager Caremark also reached an agreement with Danish drugmaker Novo Nordisk to give its weight loss drug Wegovy preferred access on Caremark’s standard formulary ...

CVS Health said it will significantly expand access to Novo Nordisk's blockbuster weight loss drug Wegovy for patients covered by its pharmacy benefit manager, Caremark. Starting July 1 ...

Novo Nordisk's Q1 showed robust sales/EPS growth, fueled by soaring GLP-1 demand in a multi-billion dollar market. Read why I ...

Evernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy (semaglutide) and Zepbound (tirzepatide) will not exceed $200. Wegovy has a ...

CVS Caremark identified GLP-1 drugs and Humira as points of contention, but the State Health Plan says that mischaracterizes ...

“With the semaglutide shortage declared over, Hims now has to transition its model to generate growth from other products ...

A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's blockbuster weight-loss drugs Ozempic and Wegovy, upholding the U.S. Food and ...

The move is part of a new partnership between Caremark and Wegovy's manufacturer, Novo Nordisk, according to CVS' first-quarter earnings release. Caremark will also drop the weight loss drug ...